Wednesday 23 September 2020
Home      All news      Contact us      India
news18 - 1 month ago

Gilead seeks U.S. approval for COVID-19 treatment remdesivir

Gilead Sciences Inc has filed an application with the U.S. Food and Drug Administration seeking full approval for remdesivir, its experimental COVID19 drug currently used under emergency authorization, the drugmaker said on Monday.


Latest News
Hashtags:   

Gilead

 | 

seeks

 | 

approval

 | 

COVID

 | 

treatment

 | 

remdesivir

 | 

Sources